BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 23, 2001
View Archived Issues
MMP inhibition with batimastat reduces inflammation in experimental colitis
Read More
First case of linezolid-resistant Staphylococcus aureus infection reported
Read More
HIV protease inhibitors associated with lipoprotein alterations and endothelial dysfunction
Read More
Novel glycoalkaloid tomatine has potential as adjuvant in malaria vaccine development
Read More
Phogen signs licensing agreement with Genencor for VP22 technology
Read More
Avigen begins second phase I trial with Coagulin-B
Read More
FDA approves combination antihistamine/decongestant Zyrtec-D
Read More
Two antiangiogenesis agents from EntreMed receive orphan drug status
Read More
Phase II study of CETi-1 cholesterol vaccine from Avant initiated
Read More
E.C. clears Resovist via mutual recognition procedure
Read More
RenaGel receives marketing approval in Brazil
Read More
Active Biotech signs letter of intent with Avidex
Read More
Schwarz updates clinical trial programs
Read More
Optison product rights agreement amended
Read More
Praecis announces meeting date with FDA regarding Plenaxis NDA
Read More
Corixa and GSK submit complete response to FDA for Bexxar
Read More
Specific PPARgamma antagonist gives insight into receptor's role in adipogenesis
Read More
Roche discloses antiproliferative derivatives useful for the treatment of solid tumors
Read More
CRF receptor antagonists reported by researchers at Eisai
Read More
Schering-Plough identifies novel selective NK1 receptor antagonists
Read More
Grelan designs new series of PDE4 inhibitors
Read More
NPY5 receptor antagonists from Schering-Plough may be useful for treating obesity and diabetes
Read More
Natrecor launch quickly follows first approval in U.S.
Read More
Synthetic vitamin D3, ED-71, significantly increases BMD, BMC and bone strength
Read More